AU4829593A - Inhalation device - Google Patents

Inhalation device

Info

Publication number
AU4829593A
AU4829593A AU48295/93A AU4829593A AU4829593A AU 4829593 A AU4829593 A AU 4829593A AU 48295/93 A AU48295/93 A AU 48295/93A AU 4829593 A AU4829593 A AU 4829593A AU 4829593 A AU4829593 A AU 4829593A
Authority
AU
Australia
Prior art keywords
inhalation device
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48295/93A
Inventor
Alastair Robert Clarke
Bruce James Renfrew
Michael Trevor Shepherd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220083A external-priority patent/GB9220083D0/en
Priority claimed from GB929220077A external-priority patent/GB9220077D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU4829593A publication Critical patent/AU4829593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
AU48295/93A 1992-09-23 1993-09-23 Inhalation device Abandoned AU4829593A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929220083A GB9220083D0 (en) 1992-09-23 1992-09-23 Inhalation device
GB9220083 1992-09-23
GB929220077A GB9220077D0 (en) 1992-09-23 1992-09-23 Inhalation device
GB9220077 1992-09-23
PCT/GB1993/002013 WO1994006498A1 (en) 1992-09-23 1993-09-23 Inhalation device

Publications (1)

Publication Number Publication Date
AU4829593A true AU4829593A (en) 1994-04-12

Family

ID=26301671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48295/93A Abandoned AU4829593A (en) 1992-09-23 1993-09-23 Inhalation device

Country Status (2)

Country Link
AU (1) AU4829593A (en)
WO (1) WO1994006498A1 (en)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492112A (en) * 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
WO1996009085A1 (en) * 1994-09-21 1996-03-28 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
JP3317823B2 (en) * 1995-08-11 2002-08-26 株式会社ユニシアジェックス Dosing device
JP3328132B2 (en) * 1996-03-21 2002-09-24 株式会社ユニシアジェックス Inhaler type dispenser
US5794613A (en) * 1997-01-09 1998-08-18 Sepracor, Inc. Multiple-dose dispenser for dry powder inhalers
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US7288390B2 (en) 2000-08-07 2007-10-30 Centocor, Inc. Anti-dual integrin antibodies, compositions, methods and uses
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
UA81743C2 (en) 2000-08-07 2008-02-11 Центокор, Инк. HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS
SE517227C2 (en) * 2000-09-25 2002-05-14 Microdrug Ag Dry powder inhaler with foil cutter
DE10128779A1 (en) † 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Process for cleaning hard gelatin capsules
CN100374457C (en) 2001-11-14 2008-03-12 森托科尔公司 Anti-IL-6 antibodies, compositions, methods and uses
AU2003215254A1 (en) 2002-02-13 2003-09-04 Immunology Laboratories, Inc. Compositions and methods for treatment of microbial infections
EP1545608A4 (en) 2002-06-28 2006-09-13 Centocor Inc Mammalian ch1 deleted mimetibodies, compositions, methods and uses
UA89481C2 (en) 2003-09-30 2010-02-10 Центокор, Инк. Human epo mimetic hinge core mimetibodies, compositions, methods and uses
WO2005040163A1 (en) 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
DE10352277A1 (en) 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
WO2005097175A2 (en) 2004-03-31 2005-10-20 Centocor, Inc. Human glp-1 mimetibodies, compositions, methods and uses
JO3058B1 (en) 2005-04-29 2017-03-15 Applied Molecular Evolution Inc Anti-IL-6 Antibodies,Compositions,Methods and uses
JP2009501006A (en) 2005-06-30 2009-01-15 セントカー・インコーポレーテツド Anti-IL-23 antibodies, compositions, methods and uses
HUE034269T2 (en) 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-il-23 antibodies, compositions, methods and uses
DE102006016901A1 (en) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
DE102006017699A1 (en) * 2006-04-15 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
JP2010500360A (en) 2006-08-10 2010-01-07 アルボア コーポレーション Local therapy of lower respiratory inflammatory diseases with inflammatory cytokine inhibitors
TW200843794A (en) 2006-12-21 2008-11-16 Centocor Inc Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
TR200803524A2 (en) * 2008-05-16 2009-12-21 Bi̇lgi̇ç Mahmut Inhalation device.
US8563697B2 (en) 2008-08-14 2013-10-22 Cephalon Australia Pty. Ltd. Anti-IL-12/IL-23 antibodies
CA2741834C (en) 2008-10-31 2022-04-05 Centocor Ortho Biotech Inc. Fibronectin type iii domain based scaffold compositions, methods and uses
EP2396011B1 (en) 2009-02-12 2016-04-13 Janssen Biotech, Inc. Fibronectin type iii domain based scaffold compositions, methods and uses
CA3033133C (en) 2009-03-25 2021-11-09 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
CN102933231B (en) 2010-02-10 2015-07-29 伊缪诺金公司 CD20 antibody and uses thereof
NZ603581A (en) 2010-06-19 2015-05-29 Sloan Kettering Inst Cancer Anti-gd2 antibodies
WO2012175735A1 (en) 2011-06-23 2012-12-27 Vib Vzw A20 inhibitors for the treatment of respiratory viral infections
TW201427681A (en) 2013-01-07 2014-07-16 Superlab Far East Ltd A method for treating tumor by using recombinant interferon with changed spatial configuration
EP2964297B1 (en) * 2013-03-08 2020-05-06 Interquim, S.A. Inhaler
KR102207859B1 (en) 2013-03-15 2021-01-27 메모리얼 슬로안 케터링 캔서 센터 High affinity anti-gd2 antibodies
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2016149368A1 (en) 2015-03-17 2016-09-22 Memorial Sloan Kettering Cancer Center Anti-muc16 antibodies and uses thereof
ES2770617T3 (en) * 2015-09-04 2020-07-02 Victor Esteve Dry powder inhaler
US20190177421A1 (en) 2016-07-15 2019-06-13 Poseida Therapeutics, Inc. Chimeric antigen receptors and methods for use
EP3484927A1 (en) 2016-07-15 2019-05-22 Poseida Therapeutics, Inc. Chimeric antigen receptors (cars) specific for muc1 and methods for their use
CA3043480A1 (en) 2016-11-09 2018-05-17 The Board Of Regents Of The University Of Texas System Methods and compositions for adaptive immune modulation
CN110267660A (en) 2016-12-16 2019-09-20 德克萨斯大学系统董事会 The inhibitor of domain protein containing Bu Luomo 4 (BRD4)
RU2730961C1 (en) * 2016-12-20 2020-08-26 Эмфэсиз Импортадора Эшпортадора Э Дистрибуидора Лтда. Dry powder inhaler
EP3574012A1 (en) 2017-01-27 2019-12-04 Memorial Sloan Kettering Cancer Center Bispecific her2 and cd3 binding molecules
CA3052095A1 (en) 2017-01-30 2018-08-02 Janssen Biotech, Inc. Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
MA47442A (en) 2017-02-07 2019-12-18 Janssen Biotech Inc ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLARTHRITIS
AU2018393110B2 (en) 2017-12-20 2023-04-27 Poseida Therapeutics, Inc. VCAR compositions and methods for use
US20190345245A1 (en) 2018-05-11 2019-11-14 Janssen Biotech, Inc. Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
US11389433B2 (en) 2018-06-18 2022-07-19 Board Of Regents, The University Of Texas System BRD4 inhibitor treatment of IgE-mediated diseases
BR112021013903A2 (en) 2019-01-15 2021-09-21 Janssen Biotech, Inc. COMPOSITIONS AND METHODS OF ANTI-TNF ANTIBODIES FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
WO2020152544A1 (en) 2019-01-23 2020-07-30 Janssen Biotech, Inc. Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
CN113840838A (en) 2019-03-14 2021-12-24 詹森生物科技公司 Methods of manufacture of compositions for the production of anti-TNF antibodies
EP3938391A1 (en) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
EP3938392A1 (en) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Methods for producing anti-tnf antibody compositions
JP2022534020A (en) 2019-05-23 2022-07-27 ヤンセン バイオテツク，インコーポレーテツド Methods of treating inflammatory bowel disease with combination therapy of antibodies against IL-23 and TNF-alpha
EP3976648A1 (en) 2019-06-03 2022-04-06 Janssen Biotech, Inc. Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
MX2021014882A (en) 2019-06-03 2022-03-25 Janssen Biotech Inc Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis.
JP7474791B2 (en) * 2019-06-24 2024-04-25 デ モトゥ コーディス ピーティーワイ リミテッド AUTOMATED DISPENSER FOR RESPIRATORY DELIVERY DEVICES - Patent application
WO2021028752A1 (en) 2019-08-15 2021-02-18 Janssen Biotech, Inc. Anti-tfn antibodies for treating type i diabetes
IL297025A (en) 2020-04-14 2022-12-01 Poseida Therapeutics Inc Compositions and methods for use in the treatment of cancer
WO2021214588A1 (en) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Anti-tnf alpha agent for treating coronavirus infections
WO2021214587A1 (en) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Anti-tnf alpha agent for treating viral infections
WO2022026943A2 (en) 2020-07-31 2022-02-03 Pinetree Therapeutics, Inc. Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infections
WO2023279115A1 (en) 2021-07-02 2023-01-05 Henry Ford Health System Compositions comprising endosidin 2 for reducing sars-cov-2 infection
US20230042465A1 (en) 2021-07-09 2023-02-09 Janssen Biotech, Inc. Manufacturing Methods for Producing Anti-TNF Antibody Compositions
AU2022306144A1 (en) 2021-07-09 2024-02-22 Janssen Biotech, Inc. Manufacturing methods for producing anti-tnf antibody compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1566604C3 (en) * 1966-09-17 1980-10-23 Fisons Pharmaceuticals Ltd., Loughborough, Leicestershire (Ver. Koenigreich) Device for the oral inhalation of medication in finely divided form
GB1268051A (en) * 1968-06-07 1972-03-22 Fisons Pharmaceuticals Ltd Inhalation device
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments

Also Published As

Publication number Publication date
WO1994006498A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU4829593A (en) Inhalation device
AU7202591A (en) Inhalation device
AU7089591A (en) Inhalation device
AU8220991A (en) Inhalation device
AU119600S (en) Inhaler device
AU5189893A (en) Catheter device
GB9217545D0 (en) Inhalation device
AU7102596A (en) Inhalation device
AU5419494A (en) Insecticidal device
AU4544593A (en) Flipover carrying device
AU121578S (en) An inhalation device
AU1444092A (en) Drop-producing device
AU4348493A (en) Inhaler
AU4125793A (en) Medico-surgical devices
AU4295993A (en) Inhalation device
AU3258793A (en) Foam-spraying device
AU7227494A (en) Inhalator
AU4591193A (en) Hand held device
AU5171893A (en) Theft-detection device
AU4949093A (en) Tinnitus-treatment device
AU687103C (en) Device for inhalation
CA71017S (en) Inhalation device
CA71018S (en) Inhalation device
CA73544S (en) Inhalation device
GB9223413D0 (en) Inhalation device